150 related articles for article (PubMed ID: 8773120)
1. Interferon in the treatment of multiple myeloma and non Hodgkins lymphoma.
Smruti BK; Nair R; Gopal R
J Assoc Physicians India; 1995; Suppl 3():33-7. PubMed ID: 8773120
[No Abstract] [Full Text] [Related]
2. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
3. Interferon in multiple myeloma--does it pay?
Kedar I; Segal A
Isr J Med Sci; 1995 Oct; 31(10):635-7. PubMed ID: 7591691
[No Abstract] [Full Text] [Related]
4. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of multiple myeloma].
Tokumine H; Machii T; Kitani T
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1100-6. PubMed ID: 7561366
[No Abstract] [Full Text] [Related]
6. Biologic therapies for low-grade lymphomas.
Parkinson DR; Sznol M; Cheson BD
Semin Oncol; 1993 Oct; 20(5 Suppl 5):111-7. PubMed ID: 8211201
[No Abstract] [Full Text] [Related]
7. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
8. Modulation of chemosensitivity by alpha interferon in multiple myeloma and non-Hodgkin's lymphoma.
Iaffaioli RV; Facchini G; Tortoriello A; Scala S; Pacelli R; La Mura G; Pagliarulo C; Palmieri G; Caponigro F
J Exp Ther Oncol; 1996 Jul; 1(4):226-30. PubMed ID: 9414408
[TBL] [Abstract][Full Text] [Related]
9. [Multiple myeloma].
Peest D
Ther Umsch; 1996 Feb; 53(2):147-51. PubMed ID: 8629265
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution.
Magagnoli M; Castagna L; Balzarotti M; Sarina B; Timofeeva I; Bertuzzi A; Compasso S; Nozza A; Siracusano L; Santoro A
Am J Hematol; 2003 Aug; 73(4):267-72. PubMed ID: 12879431
[TBL] [Abstract][Full Text] [Related]
11. [High-dose therapy of multiple myeloma with autologous hematopoietic stem cell transplantation and subsequent maintenance therapy with interferon alfa versus interferon alfa and dexamethasone--a randomized clinical study "4W"].
Mareschová I
Vnitr Lek; 1997 May; 43(5):345. PubMed ID: 9601862
[No Abstract] [Full Text] [Related]
12. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
[TBL] [Abstract][Full Text] [Related]
13. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
[TBL] [Abstract][Full Text] [Related]
14. [Autologous transplantation of peripheral hematopoietic cells and subsequent maintenance therapy with interferon alpha or interferon alpha and dexamethasone in patients with multiple myeloma--results from the 4W randomized clinical trial of the Czech Myeloma Group].
Krejcí M; Hájek R; Scudla V; Bacovský J; Indrák K; Faber E; Koza V; Schützová M; Kuca B; Sumná E; Franková H; Lehanka F; Gumulec J; Stavarová Y; Rezek Z; Praskac P; Cahová S; Vránová M; Veprek K; Januska J; Kessler P; Pozdĕnová V; Walterová L; Stefánek I; Hausdorf P; Meluzínová I; Novosadová L; Lenícková S; Dusek L; Syobodník A; Králová E; Adam Z; Mayer J; Vorlícek J
Vnitr Lek; 2001 Sep; 47 Suppl 1():40-7. PubMed ID: 11693062
[TBL] [Abstract][Full Text] [Related]
15. [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
García Laraña J; Díaz Mediavilla J; Martínez R; Lahuerta JJ; Alegre A; Odriozola J; Sureda A; San Miguel J; De la Rubia J; Escudero A; Conde E; Bladé J; Cabrera R; Gastearena J; Besalduch J; Vidal MJ; Hernández F; Rifon J; Leon A; Mataix R; Parody R; Moraleda JM; Solano C; de Pablos JM; Sánchez JJ
Sangre (Barc); 1997 Apr; 42 Suppl 1():38-41. PubMed ID: 9381300
[No Abstract] [Full Text] [Related]
16. The role of interferon in the therapy of low grade lymphoma.
McLaughlin P
Leuk Lymphoma; 1993; 10 Suppl():17-20. PubMed ID: 8481666
[No Abstract] [Full Text] [Related]
17. Inroads in the therapy of indolent lymphomas: exploiting biological insights.
McLaughlin P
Cancer Invest; 1999; 17(1):73-86. PubMed ID: 10999051
[No Abstract] [Full Text] [Related]
18. [Prognostic factors and standard therapy of multiple myeloma].
Peest D
Praxis (Bern 1994); 1998 Jun; 87(25-26):874-8. PubMed ID: 9702090
[TBL] [Abstract][Full Text] [Related]
19. [The use of thymostimulin in lymphoma and myeloma patients].
Cánovas Fernández A; Alonso Alonso J; González de Zárate P; García Masdevall MD; Riñón Martínez-Gallo M; Aguirre Errasti C
An Med Interna; 1991 Feb; 8(2):69-73. PubMed ID: 1893006
[TBL] [Abstract][Full Text] [Related]
20. The role of alpha-interferon in multiple myeloma.
Peest D
Pathol Biol (Paris); 1999 Feb; 47(2):172-7. PubMed ID: 10192884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
